Table 1.
Diagnostic performance of EP and EIE-LVC kit in serum samples from symptomatic and asymptomatic dogs.
Figure 1.
Comparison of ELISA reactivity of canine sera against PSLc6, PSLc8, PSLc10 and Mix10.
ELISA was performed in different groups of dogs (C, control group, n = 20; CVL, L. infantum group, n = 107; TC, T. cruzi group, n = 15; LB, L. braziliensis group, n = 20) against PSLc6 (A), PSLc8 (B), PSLc10 (C) and Mix10 (D).
Figure 2.
Comparison of ELISA reactivity of canine sera assessed by EIE-LVC kit.
ELISA was performed in different groups of dogs (C, control group, n = 1, given by the kit; CVL, L. infantum group, n = 107; TC, T. cruzi group, n = 15; LB, L. braziliensis group, n = 20). In A, cut off was performed according to the manufacturer; in B, it was performed using ROC curve with serum samples from control group.
Table 2.
Diagnostic performance of EP and EIE-LVC kit in a larger panel of canine serum samples.
Figure 3.
Comparison of ROC curves obtained from all the tests.
The curves were used to determine ELISA cut off, sensitivity, specificity and AUC.
Table 3.
Kappa index (κ) between paired results of diagnostic tests.